Not applicableUnknownNCT04096898What this trial is testingSenofilcon A Lenses in Moderate to Severe Dry Eye DiseaseWho this might be right forModerate to Severe Dry Eye Disease University of Illinois at Chicago 32
Testing effectiveness (Phase 2)Study completedNCT07264517What this trial is testingEvaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).Who this might be right forDry Eye Disease Instituto Grifols, S.A. 103
Large-scale testing (Phase 3)UnknownNCT05245604What this trial is testingEvaluating the Efficacy and Safety of TJO-087 in Moderate to Severe Dry Eye Disease PatientsWho this might be right forDry Eye Syndrome Taejoon Pharmaceutical Co., Ltd. 182
Not applicableStudy completedNCT06375499What this trial is testingPerformance and Safety of T2769 Versus Hylo-Forte® in the Treatment of Moderate to Severe Dry Eye Syndrome.Who this might be right forDry Eye Syndrome Laboratoires Thea 74
Not applicableLooking for participantsNCT07593885What this trial is testingEvaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Eye Drops in the Management of Moderate to Severe Dry Eye DiseaseWho this might be right forDry Eye Dr. Gerhard Mann chem.-pharm. Fabrik GmbH 160
Not applicableStudy completedNCT06607237What this trial is testingEvaluation of Safety and Efficacy of DM-28 for Treatment of Moderate to Severe Ocular DrynessWho this might be right forDry Eye Horus Pharma 44
Post-approval studies (Phase 4)Study completedNCT03608761What this trial is testingComparison Between Rebamipide 2% Versus Autologous SerumWho this might be right forDry Eye SyndromesSjögren Syndrome Hospital Nacional Profesor Alejandro Posadas 21
Not applicableUnknownNCT02424266What this trial is testingThree Dimension Tomography of Eye Structures by White Light Imaging DeviceWho this might be right forHealthy SubjectsModerate to Severe Keratoconjunctivitis Sicca (KCS)Dry Eye Syndrome (DES) Meir Medical Center 60
Large-scale testing (Phase 3)UnknownNCT06291194What this trial is testingEfficacy and Safety of AJU-S56 5% in Dry Eye Syndrome PatientsWho this might be right forDry Eye Syndromes AJU Pharm Co., Ltd. 396